Uncategorised - European Medical Journal

Resolved Hepatitis B Infection Linked to Increased Depression Risk

The study raises important concerns about the long-term mental health of individuals with resolved HBV infection.

ASCoP Registry: New Data Support Staging TAVI and PCI in Severe Aortic Stenosis

Staged TAVI and complex PCI reduce complications compared to combined procedures in patients with severe aortic stenosis.

Cancer Survivors Face Reduced Activity from Fatigue: AACR 2025

Cancer-related fatigue and depression in survivors are strongly associated with a drop in recreational physical activities and overall quality of life, according to data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025.

New Multiplex Test Boosts Detection of Tick-Borne Infections

A new multiplex protein microarray has shown promise in accurately detecting a wide range of tick-borne infections in a single test run.

Single-Dose Primaquine Cuts Malaria Spread Without Added Risk

A single low dose of primaquine, when added to artemisinin-based combination therapy, is both effective and safe for reducing Plasmodium falciparum transmission.

Restless Legs Syndrome: Updated Clinical Practice Guideline

Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) are common neurologic sleep-related conditions that affect millions of adults and children in the United States.

Emotional and Physical Toll of Childhood Atopic Dermatitis

Safety concerns surrounding certain therapies in children often lead to suboptimal management of atopic dermatitis.

Side Effects in Bladder Cancer Treatment Worse Than Estimated

The analysis included patient-reported symptoms from treatment initiation to cycle 12 of pembrolizumab.

Cytisinicline Proves Potent and Safe for Quitting Smoking

A new Phase III trial has strengthened the evidence supporting cytisinicline as an effective and well-tolerated medication for smoking cessation.

Obesity Tied to Persistent Neuropsychiatric Effects After COVID

Excess weight is emerging as a significant risk factor for neurological and neuropsychiatric symptoms in post-COVID-19 condition (PCC), according to new findings presented in a new systematic review and meta-analysis.